Cited by 267Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes Management and Research

Glucagon physiology and pathophysiology

Sherwood, Louis M., Parris, Edith E., Unger, Roger H.·1971·New England Journal of Medicine

Abstract

THE function of pancreatic glucagon has been questioned for several decades, but it now seems probable that glucagon, like insulin, is extremely important in the moment-to-moment control of the homeostasis of glucose, of certain amino acids and perhaps of free fatty acids. Normal alpha-cell function seems essential to optimal glucoregulation, and abnormal alpha-cell function may cause, contribute to or result from a variety of metabolic disorders, the most common being diabetes mellitus.Biologic Opposition of Glucagon and InsulinGlucagon has been shown to have potent glycogenolytic1 and gluconeogenic2 , 3 activity at concentrations within the physiologic range. In addition, it may have . . .

Integrity signals

Registry

Crossref · 10.1056/nejm197108192850806

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The rapid absorption of glucose after consumption of a high-GL meal increases insulin secretion, suppresses glucagon secretion, and elicits a GIP-dominant incretin response.

    “The rapid absorption of glucose after consumption of a high-GL meal increases insulin secretion, suppresses glucagon secretion, and elicits a glucose-dependent insulinotropic polypeptide (GIP)-dominant incretin response (35–37).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sherwood, L. M., Parris, E. E., & Unger, R. H.
Corresponding author
Sherwood, Louis M.
Venue
New England Journal of Medicine
Published
1971-08-19
Volume
285
Issue
8
Pages
443-449
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2038583764
Cited by
267
References
18
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 3 · 2016: 8 · 2015: 9 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
44.84
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon, alpha cells, glucose homeostasis, glycogenolysis, gluconeogenesis, diabetes mellitus, amino acid metabolism, free fatty acids
MeSH terms
Insulin Secretion, Alanine, Amino Acids, Animals, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Experimental, Dietary Carbohydrates, Dietary Proteins, Fasting, Glucagon, Gluconeogenesis, Glucose, Humans, Insulin, Pancreas, Diabetic Ketoacidosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review